- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ATTR Amyloidosis Wild Type
Total 316 results
-
Icahn School of Medicine at Mount SinaiMillennium Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
European Myeloma NetworkCompletedAL AmyloidosisNetherlands, Czechia, Austria, France, Germany, Greece, Italy, Portugal, Spain, United Kingdom
-
Boston Medical CenterJanssen PharmaceuticalsCompleted
-
Prothena Biosciences Ltd.TerminatedAL AmyloidosisUnited States
-
Andrew EisenbergerCompletedAmyloidosisUnited States
-
European Society for Blood and Marrow TransplantationCompleted
-
Nanjing University School of MedicineCompleted
-
University of TennesseeFood and Drug Administration (FDA)Completed
-
IRCCS Policlinico S. MatteoCelgene CorporationCompleted
-
Alfred Chung, MDAbbVie; Janssen PharmaceuticalsRecruitingAL Amyloidosis | Light Chain (AL) Amyloidosis | Systemic Light Chain DiseaseUnited States
-
Ionis Pharmaceuticals, Inc.CompletedAmyloidosis | Familial Amyloid Polyneuropathy | FAP | TTR | TransthyretinUnited States, Spain, Argentina, Brazil, France, Germany, Italy, Portugal, United Kingdom
-
Ionis Pharmaceuticals, Inc.CompletedAmyloidosis | Familial Amyloid Polyneuropathy | FAP | TTR | TransthyretinNew Zealand, United States, Spain, Argentina, Brazil, France, Germany, Italy, Portugal, United Kingdom
-
IRCCS Policlinico S. MatteoRecruitingAL AmyloidosisGermany, Italy, Spain, Switzerland, Netherlands
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Not yet recruiting
-
Rajshekhar Chakraborty, MDGenentech, Inc.RecruitingAL AmyloidosisUnited States
-
University of Texas Southwestern Medical CenterGlaxoSmithKlineRecruitingAL Amyloidosis | AmyloidosisUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
National Cancer Institute (NCI)Recruiting
-
Emory UniversityNational Cancer Institute (NCI); SanofiRecruitingAL AmyloidosisUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
Alexion Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
Memorial Sloan Kettering Cancer CenterVanderbilt University Medical Center; Tufts Medical CenterActive, not recruiting
-
Oncopeptides ABPRA Health SciencesTerminatedAL AmyloidosisSpain, United Kingdom, Germany, Norway, Israel, France, United States, Czechia, Greece
-
University Hospital, LimogesCompletedAmyloidosisFrance, Italy
-
University College, LondonCompleted
-
Boston Medical CenterCelgene CorporationCompletedAL AmyloidosisUnited States
-
Boston Medical CenterTerminatedAL AmyloidosisUnited States
-
Prothena Biosciences Ltd.CompletedPrimary AmyloidosisUnited States
-
Heidelberg UniversityGesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbHCompleted
-
University of TennesseeCompleted
-
Cedars-Sinai Medical CenterEnrolling by invitationAmyloidosis, Immunoglobulin Light-chainUnited States, Canada
-
Mayo ClinicCompletedAmyloidosisUnited States
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncWithdrawnAL Amyloidosis | Amyloidosis | AmyloidUnited States
-
Stanford UniversityCelgene CorporationCompletedLeukemia | AmyloidosisUnited States
-
Stanford UniversityCompletedAmyloidosis | Blood and Marrow Transplant (BMT)United States
-
Prothena Biosciences Ltd.CompletedAL AmyloidosisUnited States, Spain, Australia, Germany, United Kingdom, France, Greece, Israel, Italy, Austria
-
Tufts Medical CenterCompletedMinimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisAmyloidosis | Primary AmyloidosisUnited States
-
Marianna FontanaRecruitingExploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders (EXACLIBUR)Sudden Cardiac Death | Arrythmia | Cardiac Amyloidosis | Systemic AL AmyloidosisUnited Kingdom
-
IRCCS Policlinico S. MatteoRecruiting
-
Prothena Biosciences Ltd.Amyloidosis Research Consortium; Amyloidosis Support Groups; Amyloidosis Foundation and other collaboratorsCompletedAL Amyloidosis | AmyloidosisUnited States
-
TakedaCompletedMultiple Myeloma | Immunoglobulin Light-chain AmyloidosisSpain
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada
-
IRCCS Policlinico S. MatteoWithdrawnPrimary Amyloidosis of Light Chain TypeItaly
-
M.D. Anderson Cancer CenterCelgeneTerminatedMyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnAmyloidosis | Immunoglobulin Light Chain Deposition
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, Russian Federation, France, Korea, Republic of, Poland, Israel, Netherlands, Japan, Belgium, Greece, Switzerland, Australia, Austria, Brazil, Canada, China, Czechia, Italy, United Kingdom
-
Novartis PharmaceuticalsCompletedSolid Tumor With p53 Wild Type StatusFrance, Germany, Singapore, Switzerland, United States
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaboratorsRecruitingCardiomyopathy | Amyloidosis, PrimaryUnited States
-
Fondazione Toscana Gabriele MonasterioRecruitingAmyloid | Amyloid CardiomyopathyItaly